Skip to main content
OpenTrials
Completed

NCT Number: NCT00253019

A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods

This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

13 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Grady Memorial Hospital

Atlanta, Georgia, 30303, United States

About this study

Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 13-45 women presenting at the ambulatory surgery at Grady Memorial Hospital who want to use either oral contraceptive pills, ortho evra or depo provera?

Exclusion criteria

  • Leaving the Atlanta area within 6 months?
  • Desires pregnancy within the next 6 months?
  • Unable to provide contact information?
  • Contraindications to hormonal contraceptive?

Treatment and study plan

Primary outcomes

  1. Continuation Rates

    Time frame: 3 months

    We followed subjects to evaluate the continuation rates for subjects receiving oral contraceptive pills, Depo Provera and Ortho Evra.

Sponsors and collaborators

Lead sponsor

Emory University

Other

Registry information

Official study title

A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.

Important dates

Study start
2004
Primary completion
2005
Study completion
2005
First posted
Nov 15, 2005
Registry last updated
Aug 21, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.